[{"from": "human", "value": "Describe this molecule. [C][C][O][C][=Branch1][C][=O][O][C][C@@H1][C@H1][Branch2][Branch1][=Branch1][C@@H1][Branch2][Ring2][P][C@H1][Branch2][Ring2][N][C@@H1][Branch1][Ring2][O][Ring1][=Branch1][O][C][=N][N][Branch2][Ring1][#Branch2][C][=Branch2][Ring1][Branch1][=C][Ring1][Branch1][C][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][Branch1][C][C][C][C][C][Branch1][C][C][C][O][O][O]"}, {"from": "gpt", "value": "The molecule is an orally available prodrug of remogliflozin, a benzylpyrazole glucoside-based inhibitor of renal sodium-glucose co-transporter subtype 2 (SGLT2) with antihyperglycemic activity. Upon administration and absorption, the inactive prodrug is converted to its active form remogliflozin and acts selectively on the sodium-glucose co-transporter subtype 2 (SGLT2)."}]